Novo Nordisk is a Danish multinational pharmaceutical company that is engaged in the discovery, development, manufacturing, and marketing of medications and medical devices.
The company focuses primarily on the treatment of diabetes, obesity, hemophilia, and other bleeding disorders.
Novo Nordisk operates in more than 80 countries and employs around 45,000 people.
Some of its popular products include insulin, GLP-1, and human growth hormone.